Justia U.S. 3rd Circuit Court of Appeals Opinion Summaries

A police sergeant was injured during a training exercise when his department-issued firearm, a Sig Sauer P320 pistol, discharged while holstered. The officer did not know what had caused the trigger to move but testified that his hand was not on the weapon at the time. Emergency reports provided a slightly different account, suggesting the pistol discharged while being holstered. The officer and his wife sued the manufacturer, alleging the pistol was defectively designed, in particular because it lacked an external safety, and argued that this defect led to the injury.The case was first reviewed by the United States District Court for the Northern District of New York. The plaintiffs offered expert testimony to support their claims about the pistol’s defective design and to establish that the absence of an external safety was the cause of the injury. The district court accepted the experts’ opinions regarding the alleged design defect but excluded their causation opinions, finding them insufficiently tied to the facts of the accident. The court reasoned that the experts could not reliably explain how the accident happened or how an external safety would have prevented it. The district court then granted summary judgment for the defendant, concluding that under New York law, expert testimony was required to establish proximate causation in this case.The United States Court of Appeals for the Second Circuit reviewed the case. It determined that the district court did not abuse its discretion by excluding the causation opinions of the experts. However, the appellate court held that New York law does not always require expert testimony on proximate causation if a jury can use its own judgment along with the evidence presented. The court found that the jury could rely on the accepted design-defect opinions, the witness’s account, and its own evaluation of the firearm and holster. The court vacated the district court’s judgment and remanded the case for further proceedings. View "SLT Imports Inc v. SAR Transport Systems Pvt Ltd" on Justia Law

Whittaker, Clark & Daniels, Inc. and three affiliates, with a history of manufacturing, storing, and distributing asbestos-containing talc, faced thousands of personal injury and environmental claims. After a $29 million verdict against Whittaker in South Carolina, a state court there appointed a receiver to administer Whittaker’s assets. Whittaker’s board, without consulting the receiver, authorized and filed a Chapter 11 bankruptcy petition in the United States Bankruptcy Court for the District of New Jersey. The Debtors’ estates were largely depleted by a 2004 asset sale to Brenntag, which expressly excluded liability for pre-sale asbestos and environmental claims. The Debtors, now essentially shells, sought to settle successor liability claims against Brenntag for $535 million, but some talc claimants had already asserted such claims against Brenntag in state courts.The South Carolina receiver and the Official Committee of Talc Claimants challenged the bankruptcy filing’s validity, arguing that only the receiver could authorize such a filing under the South Carolina court's order. The receiver’s motion to dismiss the bankruptcy petition as unauthorized was denied by the Bankruptcy Court, which found the South Carolina order did not divest Whittaker’s board of its authority. The United States District Court for the District of New Jersey affirmed. In parallel, the Committee contested whether certain “product-line” successor liability claims belonged to the Debtors’ estates or to individual creditors. The Bankruptcy Court, referencing Third Circuit precedent, held that such claims were property of the bankruptcy estates.The United States Court of Appeals for the Third Circuit affirmed both lower court decisions. It held that Whittaker’s Chapter 11 filing was valid, as the South Carolina court’s receivership order did not displace the board’s authority under New Jersey law, which governs corporate internal affairs. The court further held that successor liability claims based on product-line theory, even if nominally assertable by creditors outside bankruptcy, are property of the bankruptcy estate when they address a general injury to the debtor that results in secondary harm to all creditors. Accordingly, the judgments below were affirmed. View "In re Whittaker, Clark & Daniels Inc" on Justia Law

Whittaker, Clark & Daniels, Inc. and three affiliates, historically involved in the manufacture and distribution of asbestos-containing talc, faced thousands of personal injury and environmental claims. Over the years, the companies divested their operating assets, notably selling them to Brenntag North America in 2004 while expressly excluding pre-sale asbestos and environmental liabilities. As liabilities mounted, one plaintiff obtained a large jury verdict in South Carolina and successfully moved to put Whittaker into receivership, with a receiver appointed to administer its assets.Following the South Carolina receivership, Whittaker's board authorized a Chapter 11 bankruptcy filing in the United States Bankruptcy Court for the District of New Jersey without consulting the receiver. The receiver moved to dismiss the bankruptcy, arguing that under the receivership order, only he had authority to file such a petition. The Bankruptcy Court denied the motion, finding that the receivership order did not displace the board’s authority. The United States District Court for the District of New Jersey affirmed this ruling. While bankruptcy proceedings moved forward, the Debtors negotiated a $535 million settlement with Brenntag to resolve successor liability claims. However, the Official Committee of Talc Claimants argued that certain product-line successor liability claims belonged exclusively to talc creditors and not to the bankruptcy estate.The United States Court of Appeals for the Third Circuit reviewed two central issues. First, it held that the propriety of Whittaker’s bankruptcy petition did not affect the bankruptcy court’s subject matter jurisdiction and that, under New Jersey law, the board retained authority to file for bankruptcy because the South Carolina receiver had not obtained recognition or ancillary receivership in New Jersey. Second, the court held that product-line successor liability claims, like other derivative claims based on injury to the debtor and available to all creditors, are property of the bankruptcy estate under 11 U.S.C. § 541(a)(1). Accordingly, the Third Circuit affirmed the lower courts’ judgments. View "In re: Whittaker Clark & Daniels" on Justia Law

Whittaker, Clark & Daniels, Inc. and its affiliates, former processors and distributors of industrial chemicals including talc, faced thousands of asbestos-related tort claims after selling their operating assets in 2004. In 2023, following a $29 million jury verdict in South Carolina for a plaintiff diagnosed with mesothelioma, the South Carolina Court of Common Pleas appointed a receiver to manage Whittaker’s assets. The receiver was granted broad authority to administer Whittaker’s assets and protect its interests, but the order did not explicitly remove the board’s authority over corporate affairs.Whittaker’s board, without consulting the receiver, authorized a bankruptcy filing in the United States Bankruptcy Court for the District of New Jersey. The receiver moved to dismiss the bankruptcy, arguing that only he had authority to file. The Bankruptcy Court denied the motion, finding the board retained authority under New Jersey law, and the United States District Court for the District of New Jersey affirmed. Meanwhile, the Official Committee of Talc Claimants intervened in an adversary proceeding, contesting whether certain successor liability claims against a nondebtor (Brenntag) were property of the bankruptcy estate. The Bankruptcy Court granted summary judgment to the debtors, holding that these claims belonged to the estate, and certified the decision for direct appeal.The United States Court of Appeals for the Third Circuit affirmed both lower courts. It held that an improperly filed bankruptcy petition is not a jurisdictional defect but may be grounds for dismissal. The court determined that under New Jersey law, the board retained authority to file for bankruptcy because the South Carolina receiver had not been recognized by a New Jersey court. The court also held that successor liability claims based on a “product line” theory are general claims belonging to the bankruptcy estate, not to individual creditors, following its precedent in In re Emoral. View "In re Whittaker Clark & Daniels Inc." on Justia Law

A federal immigration agent, Keith Slatowski, was injured when his Sig Sauer P320 pistol fired a bullet into his hip and out his thigh during a training session. Slatowski claimed he did not touch the trigger, only the grip, and argued that the gun's design, which lacks an external safety, made it prone to accidental discharge. He sued Sig Sauer, alleging that the gun was defectively designed and that a different safety design, such as a tabbed trigger, would have prevented the accident.The United States District Court for the Eastern District of Pennsylvania excluded the causation testimony of Slatowski's two experts, Dr. James Tertin and Dr. William Vigilante, because their conclusions were based on speculation rather than reliable testing. The court allowed their testimony on the gun's design defects but granted summary judgment for Sig Sauer, reasoning that without expert testimony on causation, the jury could not determine what caused the gun to fire.The United States Court of Appeals for the Third Circuit reviewed the case. The court affirmed the District Court's exclusion of the expert testimony on causation, agreeing that the experts' conclusions were speculative. However, the Third Circuit reversed the grant of summary judgment, holding that the jury could still determine causation based on the admissible evidence and lay testimony. The court found that the jury, with the help of expert explanations of the gun's design, could understand the remaining causation question without further expert testimony. The case was remanded for trial. View "Slatowski v. Sig Sauer, Inc." on Justia Law

In 2015, product liability cases involving the blood-pressure medication Olmesartan were consolidated into a multidistrict litigation (MDL) in the United States District Court for the District of New Jersey. Adam Slater and his law firm, Mazie Slater Katz & Freeman, LLC, represented over 200 plaintiffs, and the case settled for over $300 million. Subsequently, Anthony Martino, a plaintiff in the MDL, filed a class action in New Jersey state court against his former lawyers, alleging they received contingent fees in violation of New Jersey court rules. The case was removed to federal court and dismissed, with the dismissal affirmed on appeal.Following this, twenty-one individuals represented by the same defendants in the MDL filed a similar action in New Jersey state court, alleging breach of contract, legal malpractice, conversion, and unjust enrichment. Defendants removed the case to the District Court, citing diversity and federal-question jurisdiction. The District Court denied the plaintiffs' motion to remand, asserting ancillary enforcement jurisdiction, and granted defendants' motion for judgment on the pleadings, applying issue preclusion. The court also dismissed the parties' motions for sanctions as moot.The United States Court of Appeals for the Third Circuit reviewed the case. The court held that ancillary enforcement jurisdiction does not confer original jurisdiction sufficient for removal under 28 U.S.C. § 1441(a). The court also found that the plaintiffs' state-law claims did not necessarily raise a federal issue to establish federal-question jurisdiction. The court vacated the District Court's judgment and remanded the case to determine if the amount in controversy exceeded $75,000 for diversity jurisdiction. Additionally, the court vacated the order dismissing the motions for sanctions as moot, instructing the District Court to consider the merits of each motion. View "Johnson v. Mazie" on Justia Law

Plaintiffs alleged that an automobile manufacturer designed, manufactured, and sold defective vehicles, specifically Dodge "muscle" cars with defective rear differentials. They filed a complaint asserting state and federal causes of action based on fraud and breach of warranty. The District Court dismissed the fraud counts and some warranty counts, allowing plaintiffs to amend their complaint. After amending, the District Court dismissed the fraud counts again and some warranty counts, but allowed two warranty counts to proceed.The United States District Court for the District of Delaware initially dismissed the complaint without prejudice, allowing plaintiffs to amend it. After the plaintiffs amended their complaint, the District Court dismissed the fraud counts and some warranty counts with prejudice, but allowed two warranty counts to proceed. The plaintiffs then moved to certify the dismissal of their fraud counts for appeal under 28 U.S.C. § 1292(b) or for final judgment under Rule 54(b). The District Court denied the request for certification under § 1292(b) but granted the request for final judgment under Rule 54(b) for the fraud counts.The United States Court of Appeals for the Third Circuit reviewed the case and determined that the District Court's Rule 54(b) judgment was not final. The Court of Appeals held that the fraud and warranty counts constituted a single claim for purposes of Rule 54(b) because they were alternative theories of recovery based on the same factual situation. As a result, the judgment did not dispose of all the rights or liabilities of one or more of the parties. Consequently, the Court of Appeals dismissed the appeal for lack of jurisdiction and instructed the District Court to vacate its order directing the entry of a partial final judgment. View "Diaz v. FCA US LLC" on Justia Law

The case involves hundreds of plaintiffs who allege that they were injured by the drug Fosamax, manufactured by Merck Sharp & Dohme Corp. (Merck), due to inadequate warnings about the risk of atypical femoral fractures. The plaintiffs claim that they would not have taken the drug if they had been properly warned. Merck contends that it proposed a label change to the Food and Drug Administration (FDA) to address this risk, but the FDA rejected the proposed change due to insufficient scientific support.The United States District Court for the District of New Jersey granted summary judgment in favor of Merck, concluding that the plaintiffs' state law claims were preempted by federal law. The court found that Merck had fully informed the FDA of the justifications for the proposed warning and that the FDA had rejected the proposed label change, thus preempting the state law claims. The court relied on the FDA's Complete Response Letter and other communications to determine that the FDA's rejection was based on a lack of sufficient scientific evidence linking Fosamax to atypical femoral fractures.The United States Court of Appeals for the Third Circuit reviewed the case and vacated the District Court's judgment. The Third Circuit concluded that the District Court erred in its preemption analysis by giving too little weight to the presumption against preemption. The appellate court found that the FDA's Complete Response Letter was ambiguous and that the District Court placed too much reliance on informal FDA communications and an amicus brief to interpret the letter. The Third Circuit emphasized that the presumption against preemption is strong and that Merck did not meet the demanding standard of showing that federal law prohibited it from adding any and all warnings that would satisfy state law. The case was remanded for further proceedings. View "In re: Fosamax" on Justia Law

David Schaffner, Jr. and Theresa Sue Schaffner filed a lawsuit against Monsanto Corporation, alleging that Monsanto violated Pennsylvania law by failing to include a cancer warning on the label of its weed-killer, Roundup. The Schaffners claimed that this omission caused Mr. Schaffner to develop non-Hodgkin’s lymphoma due to his exposure to Roundup. The case was initially filed in the Court of Common Pleas of Allegheny County, Pennsylvania, and was later removed to the United States District Court for the Western District of Pennsylvania. The Judicial Panel on Multi-District Litigation (JPML) then transferred the case to the Northern District of California for consolidated pretrial proceedings.In the Northern District of California, the MDL Court had previously ruled in similar cases that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) did not preempt state-law tort duties to include a cancer warning on Roundup’s label. Following this precedent, the MDL Court denied Monsanto’s motion for summary judgment on preemption grounds. The case was subsequently remanded to the Western District of Pennsylvania, where the parties stipulated to a judgment in favor of the Schaffners, reserving Monsanto’s right to appeal the preemption issue.The United States Court of Appeals for the Third Circuit reviewed the case and focused on whether FIFRA preempted the Pennsylvania duty to warn. The court held that FIFRA’s preemption provision, which prohibits states from imposing labeling requirements different from those required under federal law, did preempt the state-law duty to include a cancer warning. The court reasoned that the Environmental Protection Agency (EPA) had approved Roundup’s label without a cancer warning, and FIFRA regulations require pesticide labels to conform to the EPA-approved label. Therefore, the Pennsylvania duty to warn was not equivalent to the federal requirements and was preempted by FIFRA. The Third Circuit reversed the judgment of the District Court. View "Schaffner v. Monsanto Corporation" on Justia Law

“Old Consumer,” a wholly owned subsidiary of J&J, sold healthcare products such as Band-Aid, Tylenol, Aveeno, and Listerine, and produced Johnson’s Baby Powder for over a century. The Powder’s base was talc. Concerns that the talc contained asbestos resulted in lawsuits alleging that it has caused ovarian cancer and mesothelioma. With mounting payouts and litigation costs, Old Consumer, through a series of intercompany transactions, split into LTL, holding Old Consumer’s liabilities relating to talc litigation and a funding support agreement from LTL’s corporate parents, and “New Consumer,” holding virtually all the productive business assets previously held by Old Consumer. J&J’s goal was to isolate the talc liabilities in a new subsidiary that could file for Chapter 11 without subjecting Old Consumer’s entire operating enterprise to bankruptcy proceedings.Talc claimants moved to dismiss LTL’s subsequent bankruptcy case as not filed in good faith. The Bankruptcy Court denied those motions and extended the automatic stay of actions against LTL to hundreds of non-debtors, including J&J and New Consumer. In consolidated appeals, the Third Circuit dismissed the petition. Good intentions— such as to protect the J&J brand or comprehensively resolve litigation—do not suffice. The Bankruptcy Code’s safe harbor is intended for debtors in financial distress. LTL was not. Ignoring a parent company’s safety net shielding all foreseen liability would create a legal blind spot. View "In re: LTL Management LLC" on Justia Law